SEMA3A and neoplasm: Consistent with the posited tumor suppressor role of this semaphorin, experimental studies ex vivo have shown that Sema3A can suppress the growth and promote the apoptosis of human leukemic cells, via diverse mechanisms; Sema4D, in contrast, was found to promote leukemia cell survival and growth 97.